HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA.

Abstract
Guinea pig isolated working hearts were exposed to 30-min ischaemia by reducing coronary flow to 10%, followed by reperfusion. Aortic output fell to 4.5+/-4.5% of the pre-ischaemic value at reperfusion, recovering to 48.2+/-14.6% at 20-min post-reperfusion; the index of myocardial stunning. IB-MECA (N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide, 3 x 10(-7) M), infused from 10 min into ischaemia, did not affect recovery of aortic output 20 min after reperfusion (41.9+/-1.9%). IB-MECA infused at reperfusion, however, significantly protected against stunning, aortic output recovering to 79.6+/-3.9% at 20-min post-reperfusion. Hypoxic gassing (5% CO(2) in nitrogen, 30 min) of guinea pig isolated paced left atria and papillary muscles reduced the developed tension, recovering to 75% 5 min after re-oxygenation. This myocardial stunning was unaffected by IB-MECA (3 x 10(-7) M) added 10 min into hypoxia. IB-MECA added at reoxygenation significantly improved recovery, which was prevented by the adenosine A(3) receptor antagonist, 1-propyl-3-(3-iodo-4-aminobenzyl)-8-(4-oxyacetate)phenylxanthine (I-ABOPX, 1 x 10(-5) M). Thus, stimulation of adenosine A(3) receptors at reperfusion/reoxygenation in guinea pig cardiac preparations protects against myocardial stunning.
AuthorsHelen L Maddock, Neil M Gardner, Nassirah Khandoudi, Antoine Bril, Kenneth J Broadley
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 477 Issue 3 Pg. 235-45 (Sep 23 2003) ISSN: 0014-2999 [Print] Netherlands
PMID14522362 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adenosine A3 Receptor Agonists
  • Receptor, Adenosine A3
  • Xanthines
  • BW A522
  • N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine
  • Adenosine
  • Oxygen
Topics
  • Adenosine (analogs & derivatives, antagonists & inhibitors, pharmacology, therapeutic use)
  • Adenosine A3 Receptor Agonists
  • Animals
  • Coronary Circulation (drug effects, physiology)
  • Endothelium, Vascular (drug effects, injuries)
  • Guinea Pigs
  • Heart Atria (drug effects, physiopathology)
  • Hypoxia (complications, drug therapy)
  • Male
  • Myocardial Ischemia (complications, drug therapy)
  • Myocardial Stunning (complications, drug therapy, prevention & control)
  • Oxygen (pharmacology)
  • Papillary Muscles (drug effects, physiopathology)
  • Perfusion
  • Receptor, Adenosine A3 (physiology)
  • Reperfusion Injury (complications, drug therapy, physiopathology)
  • Time Factors
  • Xanthines (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: